KMCRIC

For over 10 years, The World Drug Safety Congress Americas has served as the only commercially focused event for the pharmacovigilance community.

In 2019, we are proud to be the only event to gather over 30 Global Heads of Safety and Pharmacovigilance, as well as 150+ other speakers from the leading pharmaceutical companies and emerging biotechs.

The discussions will center on the advanced of next generation technology and data that have contributed to automating and improving PV methodologies, resulting in improved safety for patients. As we expand the discussions further, the 2019 edition will be featuring a predictive safety track with hundreds of toxicology, non-clinical safety executives discussing toxicity measurement & data, translational safety, predictive models and trial design.

In addition to that, our new medical device program will bring into perspective pharmacovigilance and safety approaches in apps, diagnostics, and combination products.

Our Global Pharmacovigilance track will help the industry assess the challenges and opportunities of setting a PV operation abroad, with perspectives from pharma and regulatory authorities from around the world.